The European Commission allows the use of the vaccine company AstraZeneca in the EU

“We have just authorized (use. -

) the AstraZeneca vaccine on the EU market after positive evaluation (of this drug. - RT) by the European Medicines Agency (EMA)," von der Leyen wrote.

She expects the company to deliver 400 million doses, as previously agreed.

Earlier, the European Commission demanded that AstraZeneca explain the decision to reduce by 60% the supply of vaccines from coronavirus to the EU countries.